Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
FKBP prolyl isomerase 4 pseudogene 7 (FKBP4P7) is classified as a pseudogene, meaning it is a non-coding genomic DNA sequence similar to functional genes but generally considered non-functional due to accumulated mutations that prevent expression as a working protein. It does not encode an active protein nor has defined biological functions or roles in disease. FKBP4P7 is related by sequence homology to functional FKBPs, specifically FKBP4, but it is not transcribed into a protein and thus is not a therapeutic or drug discovery target[7][5]. The presence of "pseudogene" in the name and gene description, as well as lack of reported function, protein product, or role in human disease or pharmacology, confirm it is neither an active receptor, enzyme, nor a target for any drugs[7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on FKBP prolyl isomerase 4 pseudogene 7 (FKBP4P7).